Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Xenon Could Protect Brain from Trauma Injury

By HospiMedica International staff writers
Posted on 23 Sep 2014
Treatment with xenon gas after a head injury reduces the extent of brain damage, according to a new study in mice.

Researchers at Imperial College London (Imperial, United Kingdom) conducted a study in mice that who were anesthetized before undergoing a controlled cortical impact to create a mechanical traumatic brain injury (TBI). More...
They were then treated with xenon gas at different concentrations—75%, 50%, or 30% xenon, with 25% oxygen and the balance being nitrogen—and at different times after injury. Outcomes were measured using functional neurologic outcome score, histological measurement of contusion volume, and analysis of locomotor function and gait.

The results showed that neurologic outcome scores were significantly better in xenon-treated groups in the early phase (15 minutes or one hour after injury) and up to four days after injury. Contusion volume was also significantly reduced in the xenon-treated groups, especially when xenon was given 15 minutes after injury, or when treatment was delayed up to three hours after injury. Improvements in locomotor function were observed in the xenon-treated group one month after trauma. The study was published online on September 3, 2104, in Critical Care Medicine.

“After a blow to the head, most of the damage to the brain doesn't occur immediately but in the hours and days afterwards. At present we have no specific drugs to limit the spread of the secondary injury, but we think that is the key to successful treatment,” said senior author Robert Dickinson, PhD, of the department of surgery and cancer at Imperial. “This study shows that xenon can prevent brain damage and disability in mice, and crucially it's effective when given up to at least three hours after the injury. It's feasible that someone who hits their head in an accident could be treated in the hospital or in an ambulance in this timeframe.”

Head injury is the leading cause of death and disability in people under 45 years of age in developed countries, mostly resulting from falls and road accidents. The primary injury caused by the initial mechanical force is followed by a secondary injury which develops in the hours and days afterwards, which is largely responsible for patients' mental and physical disabilities. Previous studies at Imperial found that xenon can protect brain cells from mechanical injury due to its general anesthetic properties, and it is also being studied as a treatment for babies who experience oxygen deprivation during birth.

Related Links:

Imperial College London



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.